<i>Fusobacterium nucleatum</i> drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression
Caitlin A. Brennan, Slater L. Clay, Sydney Lavoie, Sena Bae, Jessica Lang, Diogo Fonseca‐Pereira, Kathryn G. Rosinski, Nora Ou, Jonathan N. Glickman, Wendy S. Garrett
Abstract
, highlighting a conserved pathway that could potentially be targeted to slow oncomicrobe-mediated CRC.
Topics & Concepts
Fusobacterium nucleatumBiologyMicrobiologyCarcinogenesisImmune systemGut floraIntestinal mucosaImmunologyCancer researchCancerBacteriaGeneticsInternal medicineMedicinePorphyromonas gingivalisGut microbiota and healthClostridium difficile and Clostridium perfringens researchHelicobacter pylori-related gastroenterology studies